NMNH: 1. “Bonzyme” Whole-enzymatic method, environmental-friendly, no harmful solvent residues manufacturing powder. 2. Bontac is a very first manufacture in the world to produce the NMNH powder on the level of high purity, stability. 3. Exclusive “Bonpure” seven-step purification technology, high purity(up to 99%) and stability of production of NMNH powder 4. Self-owned factories and obtained a number of international certifications to ensure high quality and stable supply of products of NMNH powder 5. Provide one-stop product solution customization service
NADH: 1. Bonzyme whole-enzymatic method, environmental-friendly, no harmful solvent residues 2. Exclusive Bonpure seven-step purification technology, purity up higher than 98 % 3. Special patented process crystal form, higher stability 4. Obtained a number of international certifications to ensure high quality 5. 8 domestic and foreign NADH patents, leading the industry 6. Provide one-stop product solution customization service
NAD: 1. “Bonzyme” Whole-enzymatic method, environmental-friendly, no harmful solvent residues 2. Stable supplier of 1000+ enterprises around the world 3. Unique “Bonpure” seven-step purification technology, higher product content and higher conversion rate 4. Freeze drying technology to ensure stable product quality 5. Unique crystal technology, higher product solubility 6. Self-owned factories and obtained a number of international certifications to ensure high quality and stable supply of products
NMN: 1. “Bonzyme”Whole-enzymatic method, environmental-friendly, no harmful solvent residues 2. Exclusive“Bonpure”seven-step purification technology, high purity(up to 99.9%) and stability 3. Industrial leading technology: 15 domestic and international NMN patents 4. Self-owned factories and obtained a number of international certifications to ensure high quality and stable supply of products 5. Multiple in vivo studies show that Bontac NMN is safe and effective 6. Provide one-stop product solution customization service 7. NMN raw material supplier of famous David Sinclair team of Harvard University
Bontac Bio-Engineering (Shenzhen) Co., Ltd. (hereafter referred to as BONTAC) is a high-tech enterprise established in July 2012. BONTAC integrates R&D, production and sales, with enzyme catalysis technology as the core and coenzyme and natural products as main products. There are six major series of products in BONTAC, involving coenzymes, natural products, sugar substitutes, cosmetics, dietary supplements and medical intermediates.
As the leader of the global NMN industry, BONTAC has the first whole-enzyme catalysis technology in China. Our coenzyme products are widely used in health industry, medical & beauty, green agriculture, biomedicine and other fields. BONTAC adheres to independent innovation, with more than 170 invention patents. Different from the traditional chemical synthesis and fermentation industry, BONTAC has advantages of green low-carbon and high-value-added biosynthesis technology. What’s more, BONTAC has established the first coenzyme engineering technology research center at the provincial level in China which also is the sole in Guangdong Province.
In the future, BONTAC will focus on its advantages of green, low-carbon and high-value-added biosynthesis technology, and build ecological relationship with academia as well as upstream/downstream partners, continuously leading the synthetic biological industry and creating a better life for human beings.
What kind of coenzyme is nad+, the function and efficacy of NAD+, aging is almost human instinct. Aging brings more than just physical changes, it's a key factor in heart disease, cancer, diabetes, Alzheimer's and many other chronic diseases. Author: bili_56710380827 https://www.bilibili.com/read/cv16932994 Source: bilibili
1.Introduction A series of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease, are accompanied with bioenergetic maladaptations and axonopathy with the increasing age. As a key coenzyme in energy metabolism, nicotinamide adenine dinucleotide (NAD) plays a critical role in maintaining axonal health in central neural system. 2.NMNAT2 as the major source of NAD in cortical neurons NAD is mainly synthesized by nicotinamide mononucleotide adenylyl transferase 2 (NMNAT2). NMNAT2 is pivotal for maintaining NAD redox potential in distal axons, where it provides the adenosine triphosphate (ATP) required for fast axonal transport. Furthermore, NMNAT2 is the main source of NAD in cortical neurons, as evidenced by the reduction of NAD + and NADH levels by approximately 50% in the absence of NMNAT2. 3. The restoring effect of NAD+ supplementation on APP transport via glycolysis in the absence of NMNAT2 Exogenous NAD+ supplementation to NMNAT2-deficient neurons restores glycolysis and resumes fast axonal transport, as manifested by the diminished percentage of stationary/dynamic pause events, the elevated percentage of anterograde and retrograde events, and the restored anterograde and retrograde velocities of APP transport. 4. The molecular mechanism of NAD in protecting axonal health Remarkably, reducing the activity of SARM1, an NAD degradation enzyme, can reduce axonal transport deficits and suppress axon degeneration in NMNAT2-deficient neurons. SARM1 knockdown prevents the reduction in NAD+/NADH ratio normally caused by NMNAT2 loss. Blocking NAD+ degradation by reducing SARM1 abundance protects axons during NMNAT2 loss in vivo and in vitro. 5. Conclusion NAD+ supplementation or repressing the level of SARM1, an NAD + hydrolase, can effectively restore fast axonal transport and prevent the neurodegeneration commonly observed in NMNAT2-deficient axons both in vitro and in vivo, shedding a light on the treatment of neurodegenerative disorders of aging. Reference Yang S, Niou ZX, Enriquez A, et al. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport. Preprint. Res Sq. 2023;rs.3.rs-2859584. Published 2023 May 19. doi:10.21203/rs.3.rs-2859584/v1 About BONTAC BONTAC has dedicated to the R&D, manufacture and sale of raw materials for coenzyme and natural products since 2012, with self-owned factories, over 160 global patents as well as strong R&D team consisting of Doctors and Masters. BONTAC has rich R&D experience and advanced technology in the biosynthesis of NAD. High quality and stable supply of products can be better ensured here with the exclusive Bonpure seven-step purification technology and Bonzyme Whole-enzymatic method. Disclaimer This article is based on the reference in the academic journal. The relevant information is provide for sharing and learning purposes only, and does not represent any medical advice purposes. If there is any infringement, please contact the author for deletion. The views expressed in this article do not represent the position of BONTAC. Under no circumstances will BONTAC be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your reliance on the information and material on this website.
Powering Health and Vitality: BONTAC's Metabolism-boosting Product Portfolio In the dynamic landscape of health and wellness, the demand for cutting-edge metabolism-boosting products continues to soar. At BONTAC, we are proud to offer a diverse range of metabolism-boosting products meticulously designed to enhance cellular function, optimize metabolism-boosting health, and support overall well-being. The world of metabolism-boosting products has witnessed a remarkable evolution, and as trailblazers in the industry, BONTAC understands the significance of staying at the forefront of metabolism-boosting product development. Our dedicated team of experts tirelessly engages in research and innovation, ensuring that our metabolism-boosting products remain on the cutting edge of the industry. By constantly pushing boundaries and challenging conventional norms, we strive to deliver products that exceed expectations and address the ever-evolving needs of our valued customers. The Evolution of metabolism-boosting Products As pioneers in the industry, BONTAC recognizes the importance of staying ahead of the curve in metabolism-boosting product development. Our team of experts works tirelessly to research and innovate, ensuring that our metabolism-boosting products are at the forefront of the industry. Through a commitment to excellence and continuous improvement, we strive to meet the evolving needs of our customers. Through a steadfast commitment to excellence and a relentless pursuit of continuous improvement, we are able to anticipate emerging trends and embrace groundbreaking advancements in metabolism-boosting science. This enables us to develop innovative formulations that meet or even surpass the expectations of our discerning clientele. By harnessing the power of scientific knowledge and leveraging the latest technologies, we create metabolism-boosting products that are not only effective but also safe, reliable, and tailored to the unique requirements of individuals seeking to optimize their metabolism-boosting health. Benefits of BONTAC's metabolism-boosting Product Range BONTAC's metabolism-boosting product range is crafted with precision to enhance cellular function and energy metabolism. Our products are formulated to support optimal metabolism-boosting health, providing a foundation for long-term wellness. From boosting energy levels to optimizing metabolism-boosting processes, BONTAC's metabolism-boosting products are designed to empower individuals to live their best and healthiest life. Collaborating with BONTAC for metabolism-boosting Success When you partner with BONTAC, you gain access to customized solutions tailored to your unique business needs. Our team is dedicated to providing top-tier technical support and expertise in the metabolism-boosting industry, ensuring that you receive the guidance and resources necessary to achieve success. By partnering with BONTAC, you can leverage our commitment to technical innovation and tap into our extensive business coverage to reach new heights in the health and wellness market. Conclusion In conclusion, BONTAC's metabolism-boosting product portfolio represents the pinnacle of excellence, technical innovation, and unwavering commitment to customer success. Our products are characterized by their effectiveness, quality, and unique features that set them apart in the market. Join us on the journey to better health and vitality with BONTAC's exceptional metabolism-boosting products that are designed to transform life and empower individuals to thrive.
Introduction Elderly individuals are at a significantly higher risk for peripheral artery disease (PAD), a common vascular disorder. As the global population ages rapidly, the number of PAD cases is projected to rise further. People with PAD have increased oxidative stress, damaged skeletal muscle fibers, impaired mitochondrial activity, and poor walking performance, showing a high risk of cardiovascular and cerebrovascular events. Recently, a NICE randomized clinical trial uncovers that supplementation of nicotinamide riboside (NR) can improve the walking ability of PAD patients, opening up new opportunities for the treatment of PAD. About PAD PAD is a chronic atherosclerosis disease in which stenoses or occlusions of the peripheral arteries result in insufficient blood flow/oxygen/nutrient delivery to the distal extremity, with the typical symptoms such as ischemic rest pain, numbness of extremity, intermittent claudication and weakness of body. Herein, the testing criteria of PAD are determined as follow: a toe brachial index < 0.70, ankle brachial index (ABI) ≤ 0.90, 70% or greater stenosis in a lower extremity artery on Duplex testing, or a post-exercise ABI decline of at least 20%. The potential significance of replenishing NR in PAD As previous research demonstrated, oral administration of NR to boost NAD+ abundance can promote skeletal muscle SIRT1 expression, mitochondrial activity, limb strength as well as running endurance, activate endothelial nitric oxide synthase (eNOS) and reduce oxidative stress to increase the abundance of nitric oxide, a key vasodilator that can relax blood vessels and maintain their elasticity. All of these effects delivered by NR are contributive to the improvement of PAD. Research protocol 90 participants with PAD are randomly allocated into NR+resveratrol, NR+placebo, and placebo+placebo groups, and then are asked to take five pills daily for 6 months, including two 250 mg of NR pills (or placebo) twice daily and one 125 mg resveratrol (or placebo) once daily, followed by 3-month and 6-month follow-up. NR's impact on 6-minute walk in PAD NR meaningfully improves 6-min walk, and no added advantage is observed from resveratrol. Specifically, among participants who take at least 75% of study pills, NR improves 6-min walk by 31.0 meters and NR + resveratrol promote 6-min walk by 26.9 meters, as compared with placebo. In addition, NR increases satellite cell abundance in gastrocnemius muscle, compared to placebo, but does not affect muscle fiber type. Moreover, people randomized to NR + resveratrol report higher rates of diarrhea and higher rates of nausea or emesis, compared to those randomized to NR alone or placebo. Conclusion Supplementation of NR, to some exert, has shown potential to enhance walking performance in PAD patients. This NICE randomized clinical trial lays a preliminary foundation in establishing the feasibility of NR as a therapeutic intervention for PAD. Reference [1] Khan NA, Auranen M, Paetau I, et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med. 2014;6(6):721-731. doi:10.1002/emmm.201403943 [2] Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. Published 2018 Mar 29. doi:10.1038/s41467-018-03421-7 [3] McDermott MM, Martens CR, Domanchuk KJ, et al. Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nat Commun. 2024;15(1):5046. Published 2024 Jun 13. doi:10.1038/s41467-024-49092-5 [4] Zhang H, Ryu D, Wu Y, et al. NAD⁺ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science. 2016;352(6292):1436-1443. doi:10.1126/science.aaf2693 BONTAC NR BONTAC is one of the few suppliers in China that can launch mass production of raw materials for NR, with self-owned factory and professional R&D team. Up till now, there are 180+ BONTAC patents. BONTAC provides one-stop service for customized products. Both malate and chloride salt forms of NR are available. By dirt of unique Bonpure seven-step purification technology and Bonzyme whole-enzymatic method, the product content and conversion rate can be maintained in a higher level. The purity of BONTAC NR can reach above 97%. Our products are subjected to strict third-party self-inspection, which are worth of trustworthy. Disclaimer This article is based on the reference in the academic journal. The relevant information is provided for sharing and learning purposes only, and does not represent any medical advice purposes. If there is any infringement, please contact the author for deletion. The views expressed in this article do not represent the position of BONTAC. Under no circumstances will BONTAC be responsible for any claims, damages, losses, expenses, or costs arising directly or indirectly from your reliance on the information and material on this website.